Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Sunitinib Non Small Cell Lung Cancer Patients Over 70

ClinicalTrials.gov ID: NCT00864721

Public ClinicalTrials.gov record NCT00864721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 1:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to find out what effects (good and bad) sunitinib has on patients and their NSCLC.

Study identification

NCT ID
NCT00864721
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
US Oncology Research
Industry
Enrollment
63 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
70 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2009
Primary completion
Jun 30, 2012
Completion
Jun 30, 2012
Last update posted
Oct 15, 2018

2009 – 2012

United States locations

U.S. sites
13
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Ocala Oncology Center Ocala Florida 34471 —
Cancer Centers of Florida, P.A. Ocoee Florida 34761 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
Cancer Centers of North Carolina Raleigh North Carolina 27607 —
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401-8122 —
Cancer Centers of the Carolinas Greenville South Carolina 29605 —
Texas Oncology - Arlington South Arlington Texas 76014 —
Texas Oncology, P.A. - Bedford Bedford Texas 76022 —
Methodist Charlton Cancer Ctr. Dallas Texas 75237 —
Texas Cancer Center of Mesquite Mesquite Texas 75150 —
Texas Oncology Cancer Care and Research Center Waco Texas 76712 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Yakima Valley Mem Hosp/North Star Lodge Yakima Washington 98902 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00864721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2018 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00864721 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →